T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...
Amazon S3 on MSN
Scientists supercharge T cells to fight cancer like never before
What if cancer isn’t unstoppable — but the immune system just isn’t fully awake? Scientists at the University of Southampton ...
Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8 + T cells in patients with pancreatic ductal adenocarcinoma (PDAC), ...
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results